Clinical Trials Directory

Trials / Completed

CompletedNCT02513862

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

Prospective Randomized Trial of Autologous Platelet Rich Plasma in Reducing Allogeneic Transfusions During Aortic Surgery Under Deep Hypothermic Circulatory Arrest

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Hongwen Ji · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether autologous platelet rich plasma (APRP)is effective in reducing allogeneic blood transfusions during aortic surgery using deep hypothermic circulatory arrest.

Conditions

Interventions

TypeNameDescription
DEVICEAutologous Platelet-Rich Plasma Harvest Technique15 to 20 mL/kg of whole blood is collected before the administration of heparin from a large-bore central venous access,and is separated into red blood cells component and autologous platelet-rich plasma component by an autologous transfusion system(Sorin Group Electa Essential; Sorin Group Italia, Milan, Italy).

Timeline

Start date
2015-05-01
Primary completion
2016-06-01
Completion
2016-10-01
First posted
2015-08-03
Last updated
2016-11-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02513862. Inclusion in this directory is not an endorsement.